CU Heme Logo
Contact Us
Twitter

Homepage

The

Robert H. Allen

Memorial

Hematology Symposia

The

Robert H. Allen

Memorial

Hematology Symposia

A series for continuing education - free to those who register.

Register Here

Join Us!

BROADCAST FROM DENVER, COLORADO | NEXT SESSION OCTOBER 19, 2023!

Dr. Robert Allen

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

Dr. Allen served as the Division of Hematology Chief for nearly 40 years at University of Colorado. He dedicated his life to educating the future generation of hematologists.

MEET THE
Hematology Symposia
PRESENTERS

2023 - 2024

MEET OUR ENTIRE TEAM >
Register Here

Marc Schwartz, MD

Management of Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia in the Era of Novel Immunotherapy: Case-based Discussion
October 19, 2023

Jager Jasem, MD, MPH

Mantle Cell Lymphoma:
Challenges & Prospects
July 20, 2023

Next presenters

to be determined.

Previous Hematology Symposia
PRESENTERS

2022 - 2023

Glen Peterson

RN, DNP, ACNP
March 16, 2023

Genevieve Moyer

MD, MSC
February 16, 2023

Dan sherbenou

MD, PhD
December 15, 2022

Jonathan Gutman

MD
November 17, 2022

Tyler Buckner

MD
October 20, 2022

Gemlyn George

MD
September 15, 2022

Dan Pollyea

MD, MS
July 21, 2022

Brad Haverkos

MD
June 16, 2022

Rebecca Hunter

PhD
April 21, 2022

Mantle Cell Lymphoma: Challenges & Prospects

***

Presentation Slides

Jager Jasem, MD, MPH

Oncological Emergencies in Acute Myeloid Leukemia

This presentation will discuss the common oncological emergencies and complications associated with newly diagnosed or relapsed and/or refractory AML. This will include the diagnosis, prevention and acute management of AML complications.
Presentation Slides

Glen Peterson, RN, DNP, ACNP

Evaluation of Generalized Joint Hypermobility in Individuals with Abnormal Bleeding

This presentation will discuss the pathophysiology of connective tissue/collagen vascular disease as it relates to abnormal bleeding symptoms and review the screening tools that hematologists, primary care providers, and gynecologists should be aware. I will also discuss the hematologists’ role in managing patients with generalized joint hypermobility.
Presentation Slides

Genevieve Moyer, MD, MSC

Drug-Resistant Subpopulations in Patients with Multiple Myeloma

This presentation will discuss the treatment landscape for multiple myeloma, identify basic treatment sequencing in multiple myeloma and evaluate the potential roles of disease heterogeneity in disease response to treatment.  
Presentation Slides

Dan Sherbenou, MD, PhD

Venetoclax and Transplant in AML: Oh, the Place You'll Go!

This presentation will review the potential of venetoclax to enable and improve stem cell transplantation and to alter the paradigm of AML treatment.
Presentation Slides

Jonathan Gutman, MD

Guidelines-based Management of Von Willebrand Disease

This presentation will provide health care professionals with tools to systematically assess and quantify patients’ bleeding symptoms.
Presentation Slides

Tyler Buckner, MD

Updates in Therapeutics for Sickle Cell

This presentation will discuss the inflammation pathway involved in the pathophysiology of sickle cell disease and the underlying drugs used to target the inflammation pathway.
Presentation Slides

Gemlyn George, MD

Myeloid Malignancies and Novel Therapies

This presentation will review recent developments in the field of MDS and AML, discuss many of the new therapies approved and some that were not, and discuss promising future strategies that may be approved in the near future.
Presentation Slides

Dan Pollyea, MD, MS

A Personalized Approach for T-cell Lymphomas

This presentation will review different clinical presentations and complications of TCLs, discuss different treatment options, and outcomes.
Presentation Slides

Brad Haverkos, MD

Sexual Dysfunction Following Stem Cell Transplant

This presentation will increase health care professionals’ knowledge about the prevalence of sexual dysfunction following stem cell transplant, contributors to sexual dysfunction, how and why these issues are often unaddressed, and assessment/intervention strategies to treat sexual dysfunction following transplant.
Presentation Slides

Rebecca Hunter, PhD